Captrust Financial Advisors Organovo Holdings, Inc. Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$1.71 - $3.71 $11 - $25	-7 Reduced 1.05%	657 $1,000
Q2 2022 Aug 16, 2022	BUY	$1.71 - $3.71 $866 - $1,880	507 Added 322.93%	664 $1,000
Q1 2022 May 16, 2022	BUY	$2.74 - $4.41 $224 - $361	82 Added 109.33%	157 $1,000
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.86 $145 - $274	-40 Reduced 34.78%	75 $0
Q3 2021 Nov 16, 2021	BUY	$6.08 - $8.92 $456 - $669	75 Added 187.5%	115 $1,000
Q2 2021 Aug 16, 2021	BUY	$6.65 - $9.95 $266 - $398	40 New	40 $0
Q1 2021 May 17, 2021	SELL	$8.67 - $21.7 $60 - $151	-7 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.19 - $17.05 $50 - $119	7 New	7 $0

2.44M

17K

Ticker ONVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,712,020
Market Cap $3.22M
Description
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.